Dementia is becoming more common, and it's a big worry. Scientists have found that about 45% of dementia cases could be avoided if people changed certain habits. This is where the European project LETHE comes in. It's all about creating a digital tool to help people manage their risk factors and kee
Romiplostim is a medication that boosts platelet production in the body. It has shown potential in treating aplastic anemia, a condition where the body struggles to make enough blood cells. This drug is particularly useful for patients who haven't had success with other treatments. However, its effe
Over the past decade, China has been fine-tuning how it approves new traditional Chinese medicines (TCMs). The goal? To make the process better suit the unique nature of these treatments. This effort has led to some interesting changes in what counts as solid evidence for approval. Before the refor
Triple-negative breast cancer (TNBC) is known for being hard to treat. It grows fast and doesn't respond well to most treatments. But there's a new treatment called sacituzumab govitecan (SG) that's giving hope to patients. In a big study called ASCENT, SG was compared to standard chemotherapy. The
Polymyalgia rheumatica is a condition that causes muscle pain and stiffness. It often affects older adults. Corticosteroids are usually the go-to treatment. But what happens when they don't work or cause too many side effects? That's where sarilumab comes in. It's a medication that's been approved f
Two treatments, sotorasib and adagrasib, have received approval in the USA and Europe for tackling advanced or metastatic non-small cell lung cancer. This type of cancer is marked by a specific mutation known as KRAS G12C. Since these treatments have not been directly compared in clinical trials, re
The way clinical trials are conducted is changing. More and more, the focus is on making them easier for patients to take part in. This shift is happening because of something called decentralized clinical trials or DCTs. These trials use modern technology to bring the clinical trial experience to t
Bile duct cancers are a tough bunch to beat. They are tricky because they come in different forms and are hard to treat. For a long time, doctors have used a combo of gemcitabine and cisplatin to help patients feel better, even if it couldn't cure them. This was the go-to treatment for over ten year
The idea of helping adults with borderline personality disorder (BPD) in a shorter time frame is gaining traction. A recent effort focused on a 12-week therapy program called Road Maps. This program is designed to serve as a middle ground in the care process for those diagnosed with BPD. The goal wa
Interstitial lung diseases are a group of conditions that cause scarring of the lungs. They can lead to sudden flare-ups, known as acute exacerbations. These flare-ups are particularly tough to manage in cases of idiopathic pulmonary fibrosis, a type of lung disease with an unknown cause. The outcom
